CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 24 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $2.60 | $39K | 135,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $0.99 | $15K | 150,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $0.97 | $14K | 165,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $2.49 | $37K | 180,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $1.64 | $25K | 195,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise | +15,000 | $2.12 | $32K | 210,000 |
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2026-01-28 | Thompson Peter A. Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2025-12-04 | Jones William Benton See Remarks | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 |
Page 2 of 15 · 286 trades